Pharmaceutical Training Course Calendar

Back to details

Training format

Topic

Our Pharmaceutical calendar for the next 12 months:

Live online Classroom 2026
Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
A Practical Guide to Producing and Maintaining the PSMF Vigilance 13 16
A Practical Guide to Writing Risk Management Plans (RMPs) Vigilance 20 19
A Practical Introduction to Good Clinical Practice (GCP) GxP 15 6
AI & ML in Clinical Trials: Fundamentals, Applications, and Regulatory Aspects Artificial Intelligence (AI) in Life Sciences 11 5
AI in Pharmacovigilance Artificial Intelligence (AI) in Life Sciences 18 18
APIs in Focus: Understanding ICH, GMP and Supply Chain Excellence GxP 29-30 21-22
Achieving Publication Success in Scientific Journals Medical Writing 2 21
Additional Risk Minimization Measures (aRMMs) and Their Effectiveness Vigilance 16 2
Advanced Pharmacovigilance: From Performing Successful Due Diligence to Benefit-Risk Assessments – What to Consider Vigilance 23-25 21-25
An Essential Overview of Medical Information Regulatory Affairs 22 3
An Essential Overview of the Pharmaceutical and Biotech Industries Regulatory Affairs 12 28
An Introduction to Human Factors for Pharmaceutical and Medical Device Professionals Medical Devices 8 19
An Introduction to Signal Detection Vigilance 16 14
An Introduction to Technology Transfer for Solid Dosage Forms GxP 6 18
An Overview of EU and UK Regulatory Affairs Regulatory Affairs 11-12 21-22
An Overview of Ethical Standards in Clinical Research Publication GxP 13 11
Antimicrobial Resistance (AMR) and 'One Health': Current Challenges, Regulatory Frontiers and Future Solutions Regulatory Affairs 10 9
Behavioural Risk Management in Clinical Trials Clinical Research 13 5
Best Practice for Writing Effective SOPs Regulatory Affairs 26 14 26
Best Practices for Supplier Qualification in Life Science Medical Devices 6-7 12-13
Biosimilars Biopharma 16-17 22-23
Biotechnology for the Non-Biotechnologist Biopharma 10-12 30-4
Building The Business Case For Pharma 4.0 Medical Technology 13 6
CAPA (Corrective and Preventative Action) Regulatory Affairs 15 4
Chemistry, Manufacture and Control (CMC) - Regulatory Requirements for Biological Drug Products GxP 23-24 19-20
Cleaning Validation - Best Practice in Pharmaceuticals GxP 23-24 1-2
Clinical & Post-Marketing Safety Vigilance 11-12 16-17
Clinical Overview and Clinical Summary: Creating Effective Marketing Authorisation Application Regulatory Affairs 16-17 30-1
Clinical Quality Management Systems Clinical Research 23-24 17-18
Clinical Research Project Management Medical Devices 29-1 21-23
Clinical Trial Agreements: Key Legal, Regulatory and IP Considerations for the EU and UK Markets Commercial Contracts 18 2 24
Clinical Trial Monitoring Clinical Research 29-30 10-11
Clinical Trial Regulatory Requirements Clinical Research 2-3 14-15
Competition Law for the Pharmaceutical Industry Commercial Contracts 27
Cosmetovigilance Cosmetics 18-19 8-9
Data Integrity Auditor Masterclass GxP 22-23 14-15
Data Integrity and Document Management Medical Devices 22 8
Dealing With Scientific Journal Reviewers: From Comments to Resubmission Medical Devices 15 1
Development of Combination Products: Critical Interactions GxP 9-10 16-17
Digital CMC Medical Technology 6 2
Digital CMC: The Key To Realising Pharma 4.0 GxP 23 4
Digital Technology Transfers Medical Technology 4 22
Digital Technology and Personalisation in Patient Support Programmes Clinical Research 6 4
Drafting Commercial Contracts for the Pharmaceutical Industry Commercial Contracts 20-21 11-12
EU Pharmaceutical Regulations and Strategy Regulatory Affairs 2-3 5-6
EU Proposed Pharmaceutical Legislation Changes Regulatory Affairs 19 1
Effective Change Management in Pharma GxP 17 9
Effective Communication & Negotiation in Technology Transfers GxP 18 15
Effective Deviation Management Systems in Pharma GxP 20 25
Effective Regulatory Compliance for Storage and Distribution in Pharma Supply Chains GxP 15 20
Effective Technical Writing & Editing Medical Writing 15 18
Ensuring Clinical Research Quality & Patient Safety GxP 2 14
Essential Documentation Skills for Clinical Research Compliance GxP 9 5
GCP and Clinical Research Update - Hot Inspection Topics Clinical Research 19 20
GMP Principles in Vaccine Manufacturing GxP 16-17 8-9
Golden Rules of Being a Successful GMP Auditor GxP 5-6 30-1
Good Distribution Practices of Pharmaceuticals and APIs GxP 14-15 16-17
Good Writing Practice for Clinical Research: Ethics, Standards & Compliance GxP 20 18
How to Audit Pharmaceutical Suppliers (Material and Service) GxP 26-27 14-15
How to Deal with Difficult Situations in GMP Audits GxP 5 28
How to Interview During GMP Audits GxP 12 24
How to Manage Internal GMP Audits GxP 24-25 21-22
How to Pass International Health Authority Inspections GxP 16-17 7-8
How to Perform Bullet-Proof Good Distribution Practices (GDP) and Good Storage Practices (GSP) Audits GxP 18-19 10-11
Literature Searching in Drug Safety Vigilance 14-15 10-11
Managing Service Providers including CRO and CMOs oversight to comply with ICH GCP R3 Animal Health 13-14 15-16
Mastering CTD Submissions in the MENA Region Regulatory Affairs 19 26
Mastering Computer System Validation GxP 17-18 10-11
Mastering Ethical and Effective Scientific Publishing: Applying Good Publication Practice (GPP) Medical Writing 20 8
Mastering Grant Writing: Essential Skills for Crafting Winning Proposals Medical Writing 22-23 8-9
Measuring Performance in Clinical Research Management Clinical Research 6 23
Medical Editing for Peer-Reviewed Journals Medical Writing 8 4
Medical Writing Excellence: Crafting Compelling Scientific Documents Medical Writing 4-5 30-1
Medical Writing for Consumers Medical Writing 21 1
Medical Writing with AI Artificial Intelligence (AI) in Life Sciences 18 8
Microbiomics in Clinical Trials Clinical Research 26 14
Molecular Biology for the Non-Molecular Biologist Biopharma 20-21 8-9
Navigating EU and FDA Regulations for Drug/Device and Device/Drug Combination Products Medical Devices 2-3 14-15
Navigating ICH GCP E6 (R3): What You Need to Know Clinical Research 29 13
New EU GMP Annex 1: Compliant Sterile Medicinal Products GxP 19-21 24-26
Orphan Drug Regulatory Masterclass: EU & US Insights Regulatory Affairs 4 6
Pharmaceutical Development of ATMPs GxP 18-19 28-29
Pharmaceutical Packaging Essentials: From Regulatory Compliance to Market Success GxP 26-28 6-8
Pharmaceutical Regulatory Affairs in Africa Regulatory Affairs 6-7 3-4
Pharmaceutical Regulatory Affairs in Asia Regulatory Affairs 24-26 20-22
Pharmaceutical Regulatory Affairs in China Regulatory Affairs 3-4 25-26
Pharmaceutical Regulatory Affairs in Russia and the Eurasian Union Regulatory Affairs 5-6 30-1
Pharmaceutical Regulatory Affairs in the Middle East Regulatory Affairs 24-25 20-21
Pharmaceutical Regulatory Affairs in the Middle East and North Africa Regulatory Affairs 2-4
Pharmacovigilance Aspects of Licensing Agreements Vigilance 25 10-11
Pharmacovigilance QMS & Inspection Preparation Vigilance 27-28 8-9
Pharmacovigilance: An Overview of Drug Safety from Safety Collection to Regulatory Inspection Vigilance 30 5-6
Practical Requirements of the Arab Pharmacovigilance Guidelines Vigilance 21-22 21-22
Protein Engineering for Pharmaceutical Biotechnology Biopharma 21-22 7-8
Real World Evidence (RWE), Real World Data (RWD) and the Application of Artificial Intelligence (AI) in Pharma Artificial Intelligence (AI) in Life Sciences 22 2
Risk Evaluation and Mitigation Strategies (REMS) vs Risk Management Plans (RMP) Vigilance 12 14
Selecting the Best Scientific Journal for Your Research Medical Devices 13 19
Signal Detection and Regulatory Expectations Vigilance 2-3 30-1
Signal Detection: A Comprehensive Introduction Vigilance 28 1
Smart Packaging and Electronic Patient Information Medical Devices 15 2-3
Software Automation in Research and Development (R&D) Clinical Trials Clinical Research 17 28
Stability Testing of Pharmaceuticals and Biopharmaceuticals GxP 20-21 9-10
Successful Cognitive Testing in Clinical Drug Trials: Biomarkers, Test Selection & Integration Clinical Research 16 18
Successful Medical Writing – from Protocol to CTD Medical Writing 23-24 22-23
The 2024 EU AI Act Artificial Intelligence (AI) in Life Sciences 23 3
The Applications of Nanoparticles in the Pharmaceutical and Biomedical Industries Biopharma 11-12 15-16
The Common Technical Document GxP 27-28 14-15 21-22
The FDA Drug Approval Process Regulatory Affairs 23-24 24-25
The Principles & Applications of CRISPR Biopharma 23 7
The Regulatory Requirements on Nitrosamines in the Pharmaceutical Industry Regulatory Affairs 20-21 12-13
Thinking Outside of the GMP Box GxP 3-4 16-17
US FDA - Understanding Key Factors When Working with the FDA Biopharma 12 25
Understanding Scientific Journal Submission and Publication Medical Devices 11 16
Understanding Toxicology: A Guide for Non-Toxicologists Regulatory Affairs 19 15
Upstream and Downstream Manufacturing in the Biopharmaceutical Industry GxP 11 18
Utilising Patient Adherence Data and Digital Tools to Improve Patient Outcomes Clinical Research 16 13
Variations to Marketing Authorisations Regulatory Affairs 2-3 11-12